Home Stock

Stock Research: Sigma Healthcare

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Sigma Healthcare

ASX:SIG AU000000SIG5
60
  • Value
    23
  • Growth
    93
  • Safety
    Safety
    50
  • Combined
    67
  • Sentiment
    55
  • 360° View
    360° View
    60
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sigma Healthcare Limited is an Australian retail pharmacy franchisor and pharmaceutical wholesaler. It operates in the retail pharmacy and pharmaceutical distribution industries, with brands like Chemist Warehouse, My Chemist, Amcal, and Discount Drug Stores. It has a presence in Australia, New Zealand, Ireland, Dubai, and China. In the last fiscal year, the company had a market cap of $20,672 million, profits of $227 million, and revenue of $3,059 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 60 (better than 60% compared with alternatives), overall professional sentiment and financial characteristics for the stock Sigma Healthcare are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Sigma Healthcare. The consolidated Growth Rank has a good rank of 93, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 93% of competitors in the same industry. The consolidated Safety Rank at 50 means that the company has a financing structure that is safer than 50% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 55, which means that professional investors are more optimistic about the stock than for 55% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 23, meaning that the share price of Sigma Healthcare is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 77% of alternative stocks in the same industry. ...read more

more
Strongest Rank Price vs. Book (P/B)
Weakest Rank Profit Growth
Country Australia
Industry Health Care Distributors
Size Large
Website sigmahealthcare.com.au
Index
ASX 100
ASX 200
ASX 300
ASX 50
Sigma Healthcare stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
23 1 14 39
Growth
93 99 100 3
Safety
Safety
50 30 32 39
Sentiment
55 33 18 6
360° View
360° View
60 25 18 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
68 1 17 14
Opinions Change
56 75 50 50
Pro Holdings
n/a 33 18 40
Market Pulse
47 70 30 27
Sentiment
55 33 18 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
23 1 14 39
Growth
93 99 100 3
Safety Safety
50 30 32 39
Combined
67 29 39 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
36 3 67 91
Price vs. Earnings (P/E)
22 3 3 41
Price vs. Book (P/B)
15 5 43 75
Dividend Yield
55 6 17 27
Value
23 1 14 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
76 100 100 41
Profit Growth
96 100 98 8
Capital Growth
73 29 75 1
Stock Returns
42 100 85 11
Growth
93 99 100 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
42 74 58 54
Refinancing
60 17 30 59
Liquidity
47 10 17 8
Safety Safety
50 30 32 39

Similar Stocks

Discover high‑ranked alternatives to Sigma Healthcare and broaden your portfolio horizons.

MediPal Holdings

TYO:7459
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Sinopharm

HKG:1099
Country: China
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Perseus

ASX:PRU
Country: Australia
Industry: Gold Production
Size: Medium
Full Stock Analysis

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews